Navigation Links
Ambiguity In Patent Laws May Defer New Drug Launches

Indian Government has refused to grant product patent for Glivec, the cancer drug from Novartis AG, the Swiss pharma giant. As a result Novartis may not be able to conduct// their drug research here in India. Singapore and China are the countries where Novartis conducts its research now.

While talking on this issue, Paul Herrling, who heads Corporate Research division of Novartis reveals that this decision by the Indian government could hamper the launch of their patented products. But this in any way will not affect the distribution of Glivec here. According to him, Novartis through its foundation has been distributing Glivec to needy patients to the tune of 1270 crore in India.

Trade analysts opine that if such drugs are not available freely in the market and are being prescribed by the physicians and supplied by a few pharmacies, it would prove to be very expensive to the patients.

Herrling feels that the primary objective of any drug company should be to improve health care services. They should focus their research on this area. Product patent alone is not sufficient but data individuality is more important.
JYT
'"/>




Page: 1

Related medicine news :

1. Botched Abortions Trigger Concern Over Legal Ambiguity In Britain
2. Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations
3. HIV Patients Opposes Patenting Of AIDS Drug
4. Provigil Patent Extension Accorded To Cephalon
5. AIDS Sufferers Protest against Proposed Patent for Tenofovir
6. POLY Medicure Ltd Applies for 8 Patents, 2 FDA Approvals
7. Venus Remedies Files 5th International Patent Application
8. US Court Rules Against Lupin in Ramipril Patent Case
9. Patent for Seminal RNAi innovation Cleared in Australia
10. Canada: On Popular Demand, Tamiflu finds a Berth in the Directory of Patent Drugs
11. Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... ... February 08, 2016 , ... ... states in the U.S. require dental technicians to be certified or obtain continuing ... industry, NADL created the “What’s In Your Mouth?” campaign to inform dentists and ...
(Date:2/7/2016)... ... February 07, 2016 , ... Women's Excellence staff, in all four locations, wore ... Wear Red Day is the first Friday each February and a day to bring ... in 3 deaths among women each year – more than all cancers combined. Go ...
(Date:2/7/2016)... ... 2016 , ... Dr. Todd Hobgood , certificated in ... surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, Kybella® ... for reduction of fat below the chin (aka the “double chin”). Medication side ...
(Date:2/6/2016)... ... ... US Sports Camps is proud to sponsor the Bay Area Disc Association's ... leaders, ultimate organizations, and coaches from around the US. The theme for this year’s ... of Youth and Education, describes this year YUCC as “an important conversation we must ...
(Date:2/6/2016)... , ... February 06, 2016 , ... Shark Finds ... announce the launch of a new DRTV campaign with Belly Bands. , Having a ... everything from sprays to puppy pads and find nothing works, get Belly Bands, ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... quarter and year-end 2015 results after the Nasdaq market ... host a live conference call and webcast to discuss ... afternoon, February 11, 2016 at 4:30 p.m. Eastern Time ... --> http://www.neurocrine.com . --> Participants can ...
(Date:2/8/2016)... DUBLIN , Feb. 8, 2016 ... addition of the "Global Skin Protective Equipment ... --> http://www.researchandmarkets.com/research/fqx6nz/global_skin ) has announced ... Equipment Market 2016-2020" report to their offering. ... ( http://www.researchandmarkets.com/research/fqx6nz/global_skin ) has announced the addition of ...
(Date:2/8/2016)... Intarcia Therapeutics, Inc. today announced the appointment of ... created role of Vice President, Head of Global Medical ... of leadership experience at leading pharmaceutical, biotechnology, and health ... Most recently Dr. Yee served as VP, Head of ... Officer at AstraZeneca, where he led medical affairs across ...
Breaking Medicine Technology: